Rimonabant: A cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)156-162
Number of pages7
JournalNutrition, Metabolism and Cardiovascular Diseases
Volume16
Issue number2
DOIs
StatePublished - Mar 2006

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine

Keywords

  • Cardiometabolic
  • Cardiovascular
  • Endocannabinoid system
  • Obesity
  • Rimonabant
  • Smoking cessation

Cite this